Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster display session

652 - Colon and rectal cancer incidence are rising among young Europeans: Results from the cancer registry of Crete.

Date

09 Sep 2017

Session

Poster display session

Presenters

Dimitra Sifaki-Pistolla

Citation

Annals of Oncology (2017) 28 (suppl_5): v158-v208. 10.1093/annonc/mdx393

Authors

D. Sifaki-Pistolla1, E. Saloustros2, G. Pitsoulis3, L. Vamvakas4, D. Mavroudis4, V. Georgoulias5, C. Lionis1

Author affiliations

  • 1 Social And Family Medicine Clinic, University of Crete, School of Medicine, 71110 - Heraklion/GR
  • 2 Oncology Unit, General hospital of Heraklion 'Venizelio', 714 09 - Heraklion/GR
  • 3 Region Of Crete, Regional council, 71402 - Heraklion/GR
  • 4 Medical Oncology, University hospital of Heraklion, 71110 - Heraklion/GR
  • 5 Medical Oncology, University of Crete, School of Medicine, 71110 - Heraklion/GR
More

Resources

Abstract 652

Background

Colorectal cancer (CRC) incidence is declining rapidly overall in most European countries. Curiously, in the United States, a worrisome increase in incidence has recently been reported among young adults. We report the first study on this specific age group in the European population.

Methods

This retrospective study was conducted in Crete, Greece using data on malignant neoplasms of the colon (ICD-10: C18), rectosigmoid junction and rectum (ICD-10: C19-20). Data were obtained from the database of the regional Cancer Registry of Crete () and coded according to the international classification system for Oncology (ICD10-O-2). Information on patient’s demographic profile, personal and family medical history and lifestyle factors (smoking habits, alcohol consumption) were also available. The analysis was performed in STATA, while all tests were at a = 0.05.

Results

The mean age-specific incidence rates (ASpIR) of CRC patients

Conclusions

We confirmed in European population an increased incidence of CRC under the age of 50 and a worrisome prediction for the near future. Since mortality in young adults with CRC is high, efforts to promote research and awareness among patients and physicians about the unique characteristics of early-onset CRC are critical.

Clinical trial identification

Legal entity responsible for the study

Cancer registry of Crete

Funding

None

Disclosure

All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.